SINOVAC Initiated a Section III Scientific Trial on Bivalent Vaccine In opposition to Hand Foot and Mouth Illness (HFMD) By Investing.com
The primary section III medical trial on a multivalent HFMD vaccine on…
Immunovia to host a webcast with the chance to study extra concerning the optimistic scientific validation of its next-generation pancreatic most cancers check By Investing.com
LUND, Sweden, Dec. 16, 2024 /PRNewswire/ -- Immunovia (IMMNOV: Nasdaq Stockholm), the…
Beam Therapeutics Pronounces New Knowledge from BEACON Section 1/2 Medical Trial of BEAM-101 in Sickle Cell Illness at American Society of Hematology (ASH) Annual Assembly By Investing.com
All Seven Sufferers Handled with BEAM-101 Achieved Hemoglobin F (HbF) Induction of…
MediciNova Presents Examine Replace and Interim Evaluation of Section 2/3 Scientific Trial of MN-166 (ibudilast) in ALS (COMBAT-ALS Scientific Trial) on the thirty fifth Worldwide Symposium on ALS/MND By Investing.com
LA JOLLA, Calif., Dec. 05, 2024 (GLOBE NEWSWIRE) -- MediciNova (NASDAQ:), Inc.,…
Adicet Bio Presents Scientific Biomarker Information for Off-the-Shelf CAR T Cell Remedy in an Oral Session on the American Faculty of Rheumatology (ACR) Convergence 2024 By Investing.com
-Information exhibit traits important for therapy of autoimmune illnesses, together with strong…
Travere Therapeutics Presents Knowledge Reinforcing Scientific Advantage of FILSPARI ® (Sparsentan) in IgAN and Late-Breaking Presentation in FSGS at ASN Kidney Week 2024 By Investing.com
Practically 60% of sufferers with IgAN within the SPARTAN Research achieved full…
Europe falls behind China in taking part in host to scientific drug trials
Keep knowledgeable with free updatesMerely signal as much as the Prescription drugs…
Foresee Prescribed drugs Proclaims Preliminary Outcomes from a Part 1 Scientific Trial, Highlighting Promising Security, Tolerability and Pharmacokinetic Profile of Linvemastat (FP-020), a Novel and Choose By Investing.com
TAIPEI, Oct. 20, 2024 /PRNewswire/ -- Foresee Prescribed drugs (TPEx: 6576), ("Foresee")…
Citi lifts Akeso inventory goal with Purchase ranking on robust medical information By Investing.com
Citi has elevated its value goal for Akeso Inc (9926: HK) shares…
Research outcomes from section 1 research with exidavnemab printed in The Journal of Medical Pharmacology By Investing.com
STOCKHOLM, Aug. 27, 2024 /PRNewswire/ -- BioArctic AB (publ) (Nasdaq Stockholm: BIOA…
